| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | COO & CFO
1 company
Gordon K Johnson last filed a Form 4 in December 2019, as Chief Business Officer at ZVRA. Gordon K Johnson's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 40,000 shares of ZVRA. Net of sales, the ZVRA filings show accumulation of 40,000 shares.
Gordon K Johnson has 13 Form 4 filings on record from April 2015 to December 2019, all as Chief Business Officer at Zevra Therapeutics (ZVRA), 2015–2019.
The 20 reported transactions were 12 open-market purchases and 8 option or other derivative awards.
Counted by filing, the open-market trades come to 5 purchases worth about $59K and no sales.
The largest open-market purchase was 2,000 shares of ZVRA at an average $11.00 on April 21, 2015, about $22K.
Shares as reported in the last Form 4 for each company; the most recent is from December 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | ZVRA Zevra Therapeutics, Inc. | Chief Business Officer | Buy | 20,000 | $0.39 | $7,784.00 | +100.0% | |
| Sep 9, 2019 | ZVRA Zevra Therapeutics, Inc. | Chief Business Officer | Buy | 10,000 | $0.82 | $8,168.10 | +100.0% | |
| Oct 12, 2018 | ZVRA Zevra Therapeutics, Inc. | Chief Business Officer | Buy | 4,000 | $2.61 | $10,456.60 | +66.7% | |
| Aug 24, 2017 | ZVRA Zevra Therapeutics, Inc. | Chief Business Officer | Buy | 4,000 | $2.60 | $10,403.80 | +200.0% | |
| Apr 21, 2015 | ZVRA Zevra Therapeutics, Inc. | COO & CFO | Buy | 2,000 | $11.00 | $22,000.00 | New |